What Does TwistJECT® Auto-injector Cost?

Pricing incomplete — we need real-world quote data

The TwistJECT® Auto-injector is a specialized parenteral delivery device with extremely limited public pricing information. Unlike established epinephrine or biologic auto-injectors, the TwistJECT product lacks published list prices, GSA contracts, or transparent wholesale costs. This article will be updated as MedSource collects actual procurement quotes.

Market context: Why auto-injector prices vary widely

Average retail prices for autoinjectors have increased from less than $100 prior to 2010 to more than $600 for some devices.

The extensive process of research and development for autoinjectors entails the employment of cutting-edge technologies, which raises production costs and yields expensive final products. For the TwistJECT specifically, pricing will depend on:

• Drug combination status: Whether it's sold as a device-only platform or as a finished formulation with drug filled
• Regulatory pathway: FDA 510(k) clearance vs. NDA/BLA as a combination product
• Manufacturing maturity: Pre-launch vs. established supply chain
• Clinical indication: Emergency vs. chronic-use positioning affects market tier

What typically costs more in auto-injector procurement

As of May 30, 2022, the FDA recognized ISO 11608-1:2022 and encouraged autoinjector manufacturers to adopt these ISO standards to demonstrate conformity with FDA requirements. Devices that meet stricter performance specifications—particularly holding force, cap removal force, activation force, extended needle length, injection time, dose accuracy and needle guard lockout —command premium pricing.

If TwistJECT incorporates advanced features such as:

• Electronic or automated activation mechanisms
• Connected health monitoring (dose logging, Bluetooth)
• Adjustable needle depth
• Integrated safety lockouts

…expect pricing in the $400–$800 per-unit range, based on comparable market devices.

What reduces cost: Mechanical simplicity and volume

The market is divided into mechanical (spring-based) autoinjectors and electronic autoinjectors; in 2025, mechanical autoinjectors led due to their cost-effectiveness and minimal training needs, with established manufacturing process, ease of large-scale production, and lower risk of device failure.

If TwistJECT uses a spring-loaded design without electronic components, unit cost in volume (500+ units annually) could fall to $200–$400. Reusable platforms typically cost 30–50% more upfront but reduce per-injection cost over time.

Hidden costs beyond device price

Compatibility and storage: If TwistJECT is indication-specific (e.g., for adrenal crisis treatment), validate that your current pharmacy cold-chain, shelf-life tracking, and automatic dispensing systems are compatible.

User training: Advances such as ergonomic designs, safety shields, and connected features that track dose history further enhance usability and clinician oversight. Budget for staff certification if your team must demonstrate proper use to patients or caregivers.

Sharps disposal and waste management: All auto-injectors are sharps. Ensure your disposal contracts account for increased volume.

Regulatory support: If TwistJECT is newly approved or still in limited distribution, verify that FDA-approved patient training materials, provider resources, and replacement protocols are in place before committing to a pilot.

How to negotiate and source

1. Request manufacturer quotes directly. SOLUtion Medical should provide tiered pricing for clinical trial, pilot, or commercial volumes.
2. Check GPO contracts: NOVAMED, Healthtrust, or other hospital purchasing organizations may have negotiated agreements; these typically offer 15–25% discounts off list.
3. Bulk purchase commitments: Committing to annual volumes of 100+ units often yields 20–30% price reductions.
4. Reimbursement alignment: Confirm that your payer mix covers TwistJECT at a rate that supports profitability if billing for administration or dispensing.

Red flags in pricing

• Pricing absent from manufacturer website: Newly cleared or experimental devices often lack transparent pricing until supply stabilizes; verify FDA status before piloting.
• Extreme variance by distributor: If different suppliers quote $150 vs. $500 for identical products, investigate whether you're comparing device-only vs. drug-loaded units.
• Bundled drug-device pricing: Some products lock you into buying drug refills from a single supplier; cost per unit may appear low but total-of-ownership rises sharply.

What we don't yet know

• Retail/list price from manufacturer
• GPO contract availability and discount tier
• Insurance reimbursement codes (HCPCS)
• Shelf-life and storage requirements
• Minimum order quantities
• Whether single-use or reusable platform

Next steps for procurement officers

This article will be updated when real-world quotes are collected. In the meantime:

• Contact SOLUtion Medical directly for current pricing and availability.
• Request a pilot proposal (typically 10–50 units) to evaluate clinical fit before negotiating volume contracts.
• Confirm FDA clearance status and any post-market surveillance requirements.
• Benchmark against comparable devices (e.g., EpiPen, Auvi-Q, or drug-specific auto-injectors in your therapeutic area).

---

Sources

Healthcare Packaging article on TwistJECT development (SOLUtion Medical)

FDA guidance and ISO 11608-1:2022 standards on auto-injector primary functions

Journal of Allergy and Clinical Immunology pricing trends

Auto-injector market segmentation on mechanical vs. electronic devices (Markets and Markets 2026)

• FDA Technical Considerations guidance documents (21 CFR, combination product pathways)

---

Note: MedSource maintains this article as a living document. If you have verified pricing for TwistJECT® Auto-injector, submit it via our feedback channel to accelerate updates for other procurement professionals.